Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Totaro

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Urologia Internationalis|October 16, 2009
Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardizationP F Bassi, A Volpe, M Racioppi, et al.
Annales De Genetique|January 1, 1997
A recombination event close to HFE gene in hereditary hemochromatosisA Roetto, L Sbaiz, S Bosio, et al.
The New England Journal of Medicine|September 2, 1999
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis geneA Pietrangelo, G Montosi, A Totaro, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 29, 2013
Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure RegistryM Correale, A Totaro, T Passero, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadineB V Clineschmidt, M A McKendry, N L Papp, et al.
Life Sciences|January 1, 1989
[3H]L-657,743 (MK-912): a new, high affinity, selective radioligand for brain alpha 2-adrenoceptorsD J Pettibone, S D Flagg, J A Totaro, et al.
Urologia|October 5, 2010
[Doping and urologic tumors]F Pinto, E Sacco, A Volpe, et al.
Human Genetics|April 1, 1995
New polymorphisms and markers in the HLA class I region: relevance to hereditary hemochromatosis (HFE)A Totaro, A Grifa, A Roetto, et al.
Haematologica|May 9, 2000
Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?A Iolascon, V Servedio, R Carbone, et al.
Blood|April 21, 2001
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3A Roetto, A Totaro, A Piperno, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Urologia Internationalis|October 16, 2009
Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardizationP F Bassi, A Volpe, M Racioppi, et al.
Annales De Genetique|January 1, 1997
A recombination event close to HFE gene in hereditary hemochromatosisA Roetto, L Sbaiz, S Bosio, et al.
The New England Journal of Medicine|September 2, 1999
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis geneA Pietrangelo, G Montosi, A Totaro, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 29, 2013
Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure RegistryM Correale, A Totaro, T Passero, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadineB V Clineschmidt, M A McKendry, N L Papp, et al.
Life Sciences|January 1, 1989
[3H]L-657,743 (MK-912): a new, high affinity, selective radioligand for brain alpha 2-adrenoceptorsD J Pettibone, S D Flagg, J A Totaro, et al.
Urologia|October 5, 2010
[Doping and urologic tumors]F Pinto, E Sacco, A Volpe, et al.
Human Genetics|April 1, 1995
New polymorphisms and markers in the HLA class I region: relevance to hereditary hemochromatosis (HFE)A Totaro, A Grifa, A Roetto, et al.
Haematologica|May 9, 2000
Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?A Iolascon, V Servedio, R Carbone, et al.
Blood|April 21, 2001
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3A Roetto, A Totaro, A Piperno, et al.
Pageof 9